Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.
Read Full NewsUse of immediate-release amantadine as an add-on to levodopa reduced peak-dose dyskinesia incidence in patients with early Parkinson disease, according to results from the phase 2 PREMANDYSK trial.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 16, 2026.
The therapy also received orphan drug designation from the FDA.
Phase 3 MODIFY Shows No Significant Renal Benefit With Lucerastat in Fabry Disease
HCPLive 5 Stories in Under 5: Week of 01/11
Topical Antioxidant Serum May Be Effective in Treating Atrophic Acne Scars
1.
Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.
2.
Young adults who are obese are at risk for 17 different types of cancer in the future.
3.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
4.
For patients with prostate cancer, long-term follow-up helps identify treatment side effects.
5.
Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.
1.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
2.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
3.
How Cancer Cells Evade Immune Destruction and the Fight Back
4.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
5.
Understanding the Importance of Knowing Your MCV Normal Range
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
3.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge